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Abstract
Osteopontin (OPN) is a multifunctional protein that plays important roles in cell growth, differentiation, migration and tissue
fibrosis. In human idiopathic pulmonary fibrosis and murine bleomycin-induced lung fibrosis, OPN is upregulated in type II
alveolar epithelial cells (AEC II). However, the mechanism of OPN induction in AEC II is not fully understood. In this study, we
demonstrate the molecular mechanism of OPN induction in AEC II and elucidate the functions of OPN in AEC II and lung
fibroblasts. Human lung adenocarcinoma cells (A549) and mouse alveolar epithelial cells (MLE12), used as type II alveolar
epithelial cell lines for in vitro assays, and human pulmonary alveolar epithelial cells (HPAEpiC) were treated with either
bleomycin, doxorubicin or tunicamycin. The mechanism of OPN induction in these cells and its function as a pro-fibrotic
cytokine on A549 and lung fibroblasts were analyzed. The DNA damaging reagents bleomycin and doxorubicin were found
to induce OPN expression in A549, MLE12 and HPAEpiC. OPN expression was induced via activation of the extracellular
signal-regulated protein kinase (ERK)-dependent signaling pathway in A549 and MLE12. The endoplasmic reticulum (ER)
stress-inducing reagent tunicamycin induced OPN mRNA expression in A549, MLE12 and HPAEpiC, and OPN mRNA
expression was induced via activation of the ERK-dependent signaling pathway in A549 and MLE12. Another ER stress-
inducing reagent thapsigargin induced the expression of OPN mRNA as well as the subsequent production of OPN in A549
and MLE12. Furthermore, OPN promoted the proliferation of A549 and the migration of normal human lung fibroblasts.
Inhibition of OPN by small interference RNA or neutralizing antibody suppressed both of these responses. The results of this
study suggest that cell stress induces the upregulation of OPN in AEC II by signaling through the ERK pathway, and that
upregulated OPN may play a role in fibrogenesis of the lung.
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Introduction
Idiopathic pulmonary fibrosis (IPF) is a progressive and often
lethal lung disorder. The histopathological features of IPF are
usual interstitial pneumonia, which consists of honeycombing,
patchy fibrosis, fibroblastic foci and hyperplasia of type II
pneumocytes [1]. The mechanism of IPF remains poorly
understood. Previously, it was thought that chronic lung inflam-
mation causes fibrogenesis and, eventually, fibrotic scarring.
However, therapeutic strategies based on anti-inflammatory
treatments or immunosuppressive approaches have not been
effective in the treatment of IPF. Recent reports suggest that IPF is
associated with abnormal repair of injured alveolar epithelium [2].
When alveolar epithelium is injured, type II alveolar epithelial cells
(AEC II) undergo hyperplasia and become suppliers of fibrogenic
cytokines that induce the proliferation and migration of lung
fibroblasts [3]. Potential causes of alveolar epithelium injury
include DNA damage and endoplasmic reticulum (ER) stress [4,5].
Osteopontin (OPN) is a glycosylated phosphoprotein that
contains an arginine-glycine-aspartate integrin binding domain.
OPN was first identified as a bone matrix protein with an adhesive
function owing to its integrin binding activity. Recently, OPN has
been shown to be expressed in various tissues and to be
upregulated under pathological as well as physiological conditions.
Consequently, investigators have focused on the roles of OPN in
the pathogenesis of various diseases and its pathological roles as a
pro-inflammatory and pro-fibrotic cytokine [6,7].
OPN is upregulated in the tissues of human IPF and murine
bleomycin-induced lung fibrosis [7–9]. In normal lungs, OPN is
mainly expressed in alveolar macrophages, whereas in human IPF
and murine bleomycin-induced lung fibrosis, OPN is upregulated
in hyperplastic AEC II [7–9]. Additionally, in murine bleomycin-
induced lung fibrosis, OPN-deficient mice develop altered lung
fibrosis characterized by dilated distal air space and decreased type
I collagen expression compared to wild-type mice [9]. These
reports suggest that the expression of OPN might be induced in
AEC II of human IPF and murine bleomycin-induced lung fibrosis
and that OPN may play a role in epithelial repair and
regeneration. However, the detailed mechanism of OPN induction
in AEC II is not fully understood. In this study, we elucidate the
molecular mechanism of OPN induction in AEC II by bleomycin,
doxorubicin and tunicamycin. We also demonstrate that upregu-
lated OPN plays a crucial role in the proliferation of AEC II and
the migration of lung fibroblasts.
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Materials and Methods
Reagents and antibodies
Bleomycin and tunicamycin were purchased from Sigma-
Aldrich (St. Louis, MO, USA). Doxorubicin and thapsigargin
were purchased from Wako Pure Chemical Industries, Ltd.
(Osaka, Japan). PD98059 and U0126 were purchased from
Calbiochem (La Jolla, CA, USA). Anti-phospho-specific p44/42
mitogen-activated protein kinase (MAPK) (extracellular signal-
regulated protein kinase1/2 (ERK1/2)), anti-ERK1/2, anti-
phospho-specific stress-activated protein kinase (SAPK)/c-Jun
NH2-terminal kinase (JNK), anti-SAPK/JNK, anti-phospho-spe-
cific p38 MAPK, anti-p38 MAPK, anti-b-actin, anti-immuno-
globulin heavy-chain binding protein (BiP) antibodies and
horseradish peroxidase (HRP)-conjugated secondary antibody
were purchased from Cell Signaling Technology (Danvers, MA,
USA). Recombinant human OPN was purchased from R&D
Systems (Minneapolis, MN, USA). Anti-human OPN neutralizing
antibody (anti-OPN IgG) and its nonspecific control antibody
(control IgG) were purchased from R&D Systems.
Cell culture
Human lung adenocarcinoma cells (A549) and mouse alveolar
epithelial cells (MLE12) from American Type Culture Collection
(Manassas, VA, USA) were cultured in Dulbecco’s Modified Eagle
Medium (DMEM) and DMEM/Ham’s F-12, respectively, sup-
plemented with 10% fetal bovine serum (FBS) and antibiotics
(100 U/mL penicillin and 100 mg/mL streptomycin). These cells
exhibit the cuboidal cell morphology of AEC II. Human
pulmonary alveolar epithelial cells (HPAEpiC) from ScienCell
Research Laboratories (Carlsbad, CA, USA) were cultured in
alveolar epithelial cell medium (ScienCell Research Laboratories)
with poly-L-lysine-coated culture vessels (Corning Incorporated,
Tewksbury, MA, USA). Normal human lung fibroblasts (NHLFs)
from Lonza (Walkersville, MD, USA) were cultured in DMEM
supplemented with 10% FBS and antibiotics.
Quantitative real-time reverse transcription polymerase
chain reaction (qRT-PCR)
Total RNA was extracted with Isogen II reagent from Nippon
Gene (Tokyo, Japan) according to the manufacturer’s protocol.
Complementary DNA (cDNA) was synthesized from total RNA
with a first-strand cDNA synthesis kit, SuperScript VILO cDNA
Synthesis Kit from Life Technologies (Carlsbad, CA, USA),
according to the manufacturer’s protocol. qRT-PCR was
performed with a LightCycler 480 SYBR Green I Master from
Roche (Basel, Switzerland) with the LightCycler 480 instrument
(Roche). Cycle threshold values of OPN were normalized to those
of b-actin (ACTB). Sequences of primers used for qRT-PCR were
as follows: human OPN, 59-AAGCGAGGAGTTGAATGGTG-
CAT-39 (sense) and 59-TGTGGGTTTCAGCACTCTGGTCA-
39 (antisense); human ACTB, 59-CTGGAACGGTGAAGGT-
GACA-39 (sense) and 59-AAGGGACTTCCTGTAACAA-
TGCA-39 (antisense); mouse Opn, 59-GTATTGCTTTTGCC-
TGTTTGG-39 (sense) and 59-TGAGCTGCCAGAATCAGT-
CACT-39 (antisense); mouse Actb, 59-GGCTGTATTCCCCTC-
CATCG-39 (sense) and 59-CCAGTTGGTAACAATGCCATGT-
39 (antisense). Each experiment was performed in triplicate and
repeated at least three times.
Enzyme-linked immunosorbent assay (ELISA)
Cells were lysed in M-PER Mammalian Protein Extraction
Reagent (Thermo Fisher Scientific Inc., Walthem, MA, USA) and
Halt Protease Inhibitor Single-Use Cocktail EDTA-Free (Thermo
Fisher Scientific Inc.) was added at a concentration of 10 mg/mL.
OPN concentrations in cell lysates and cell culture media were
determined by ELISA, using the Human Osteopontin Assay Kit
from Immuno-Biological Laboratories (Gunma, Japan) according
to the manufacturer’s protocol. All samples were prepared in
duplicate and each experiment was repeated at least three times.
Western blotting
Each sample was separated by sodium dodecyl sulphate-
polyacrylamide gel electrophoresis, and subsequently transferred
to polyvinylidene difluoride membranes. The membranes were
blocked with Tris-buffered saline containing 0.1% Tween20 (TBS-
T) and 0.1% Block Ace Powder from DS Pharma Biomedical
(Osaka, Japan), followed by incubation with a primary antibody.
After washing with TBS-T, the membranes were incubated with
an HRP-conjugated secondary antibody and then washed with
TBS-T again. Immunoreactive proteins were detected by
enhanced chemiluminescence using the Amersham ECL Prime
Western Blotting Detection Reagent from GE Healthcare (Little
Chalfont, Buckinghamshire, UK). Each experiment was repeated
at least three times.
RNA interference
Small interference RNA (siRNA) against human OPN and
control siRNA were purchased from Qiagen (Venlo, Netherlands).
The transfection of siRNA was performed with a Lipofectamine
RNAiMAX Reagent from Life Technologies according to the
manufacturer’s protocol.
Cell proliferation assay
To quantitate cell proliferation, DNA replication was assessed
using the Click-iT 5-ethynyl-29-deoxyuridine (EdU) Alexa Fluor
488 HCS assay kit from Life Technologies, according to the
manufacturer’s protocol. Twenty-four h after the transfection of
human OPN siRNA or control siRNA, A549 were reseeded into 6-
well plates and exposed to 1 mg/mL bleomycin for 48 h.
Thereafter, the A549 were incubated with EdU for an additional
15 h and then fixed with 4% paraformaldehyde in PBS (Wako
Pure Chemical Industries, Ltd.) for 15 minutes at room
temperature. The fixed A549 in each well were washed twice
with 3% bovine serum albumin (BSA) in PBS and permeabilized
with 0.5% Triton X-100 in PBS for 20 minutes at room
temperature. The permeabilized A549 in each well were again
washed twice with 3% BSA in PBS, and subsequently incubated
with 480 mL of Click-iT reaction cocktail for 30 minutes at room
temperature in the absence of light. Thereafter, the A549 were
washed once with 3% BSA in PBS and once with PBS and then
incubated with HCS NuclearMask Blue stain in PBS for 30
minutes at room temperature in the absence of light. After washing
twice with PBS, the A549 were then visualized by pseudocoloring
with the Floid Cell Imaging Station (Life Technologies). Prolifer-
ating cells incorporate EdU into newly synthesized DNA as a
nucleoside analog of thymidine. Consequently, the nuclei of
proliferating cells showed green fluorescence as EdU-positive
nuclei after treatment with Alexa Fluor azide. The nuclei of all
cells showed blue fluorescence following treatment with HCS
NuclearMask Blue stain. Twelve fields per well were recorded with
the Floid Cell Imaging Station and the number of positively-
staining cells was counted. This experiment was performed in
triplicate and repeated at least three times.
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Cell migration assay
Cell migration assay was performed using the xCELLigence
Real-Time Cell Analyzer (RTCA) Dual-Plate (DP) instrument
(Acea Biosciences, San Diego, CA, USA) which was placed at
37uC in a humidified 5% CO2 incubator. Cell migration was
assessed using specifically designed 16-well plates with 8 mm pores
(CIM-plate 16, Acea Biosciences). These plates are similar to
conventional transwell plates but exhibit microelectrode sensors
located on the underside of the membranes of the upper chamber.
When cells migrate through the pores of the membrane and
contact the electronic sensors, the impedance of the electronic
sensors is increased. These changes in impedance are monitored in
real-time as cell index. The membranes of the upper chamber
were coated with 20 mg/mL fibronectin from Roche. This
experiment was performed according to the manufacturer’s
protocol. NHLFs were cultured with DMEM supplemented with
0.1% FBS and antibiotics for 18 h to allow for serum starvation.
These cells were then resuspended in DMEM supplemented with
antibiotics (serum-free DMEM) and seeded into the upper
chamber at 15,000 cells/well. Cell culture medium in which
A549 in serum-free DMEM were exposed to 1 mg/mL bleomycin
for 48 h was designated ‘‘Conditioned medium’’. OPN concen-
tration in the conditioned medium was determined by ELISA and
was approximately 1.05 mg/mL. The lower chamber was filled
with either conditioned medium +4 mg/mL control IgG, condi-
tioned medium +4 mg/mL anti-OPN IgG, or serum-free DMEM
+4 mg/mL control IgG. The cell index was monitored automat-
ically every 15 minutes for at least 24 h with the xCELLigence
RTCA DP instrument. In some cases, the serum-free DMEM
supplemented with 1 mg/mL recombinant human OPN, at a
concentration similar to that in the conditioned medium, was used.
The lower chamber was filled with either serum-free DMEM+
1 mg/mL recombinant human OPN+4 mg/mL control IgG,
serum-free DMEM+1 mg/mL recombinant human OPN+4 mg/
mL anti-OPN IgG, or serum-free DMEM+4 mg/mL control IgG.
The cell index was monitored similarly. Data analysis was
performed with RTCA software version 1.2. This experiment
was performed in triplicate and repeated at least three times.
Statistical analysis
Data from two subgroups were analyzed with the Mann-
Whitney U test. Data among more than two subgroups were
analyzed by ANOVA followed by the Tukey-Kramer test. All data
were expressed as mean 6 S.E. Differences were considered
significant if P,0.05.
Results
Bleomycin-induced OPN expression in AEC II
We first sought to determine whether bleomycin would alter
OPN mRNA expression in AEC II. After 48 h of exposure of A549
to 1 mg/mL bleomycin, the expression of OPN mRNA was
elevated (Figure 1A). To confirm whether bleomycin would also
alter OPNmRNA expression in other type II alveolar epithelial cell
lines, MLE12 were exposed to 1 mg/mL bleomycin. Similar to
A549, after 48 h of exposure to 1 mg/mL bleomycin, the
expression of Opn mRNA was elevated in MLE12 (Figure 1B).
Both A549 and MLE12 were subsequently exposed to 0, 1 and
10 mg/mL bleomycin for 48 h. Compared with 1 mg/mL, 10 mg/
mL bleomycin induced higher OPN mRNA expression after 48 h
(Figures 1C and 1D). Next, we sought to determine whether
bleomycin would induce the production of OPN in A549. During
6 d of cultivation, OPN was upregulated spontaneously over time
in both cell lysates and cell culture media. The accumulation of
OPN in cell culture media was greater compared to that in cell
lysates (Figures 1E and 1F). The addition of 1 mg/mL bleomycin
reduced OPN in cell lysates at 2 d compared to the vehicle control
(Figure 1E); however, it increased the total amount of OPN from
cell lysates and cell culture media at 2, 4 and 6 d compared to the
vehicle control (Figure 1G). These results suggest that treatment
with bleomycin induces the expression of OPN mRNA and
subsequent production of OPN in AEC II.
Bleomycin-induced OPN expression via activation of the
ERK-dependent signaling pathway
The exposure of bovine endothelial cells or murine broncho-
alveolar lavage fluid cells to bleomycin activates MAPKs [10,11].
Furthermore, the activation of MAPKs induces the expression of
OPN in rat cardiac fibroblasts and human periodontal ligament
fibroblasts [12,13]. Therefore, we sought to determine whether
MAPKs are activated when A549 were exposed to bleomycin.
ERK1/2 phosphorylation was induced in A549 after 24 h of
exposure to 10 mg/mL bleomycin, without significant changes to
total ERK1/2 protein levels. Moreover, bleomycin did not induce
phosphorylation of SAPK/JNK or p38 MAPK in A549
(Figure 2A). To confirm these results, MLE12 were exposed to
10 mg/mL bleomycin. In MLE12, Erk1/2 phosphorylation was
induced after 36 h of exposure, without significant changes to total
Erk1/2 protein levels (Figure S1).
To clarify whether the ERK-dependent signaling pathway is
responsible for bleomycin-mediated expression of OPN, we
employed the use of two specific ERK1/2 inhibitors, PD98059
and U0126 [14,15], and observed that at concentrations of
50 mM, both inhibited ERK1/2 phosphorylation after 48 h of
bleomycin exposure, without significant changes to total ERK1/2
protein levels in A549 (Figures 2B and 2C) and MLE12 (Figures
S2A and S2B). A549 were also pretreated with either PD98059
(50 mM) or U0126 (50 mM) for 1 h, after which the cells were
exposed to either 10 mg/mL bleomycin or PBS for an additional
48 h. The presence of the inhibitors significantly reduced the
expression of OPN mRNA (Figures 2D and 2E) as well as the
accumulation of OPN in cell culture media (Figures 2F and 2G).
To confirm these results, MLE12 were also pretreated with either
PD98059 (50 mM) or U0126 (50 mM) for 1 h, after which the cells
were exposed to either 10 mg/mL bleomycin or PBS for an
additional 48 h. The presence of the inhibitors was found to
significantly reduce expression of Opn mRNA in MLE12 (Figures
S3A and S3B). These data suggest that bleomycin induces OPN
expression via activation of the ERK-dependent signaling pathway
in AEC II.
Doxorubicin-induced OPN expression in AEC II via
activation of the ERK-dependent signaling pathway
Bleomycin causes cellular injury through DNA strand breaks.
To confirm whether cellular injury as a result of DNA damage
would induce OPN expression in AEC II, we investigated the use
of another reagent that causes cellular injury via inhibition of
DNA topoisomerase, namely doxorubicin [16]. A549 and MLE12
were exposed to 50 nM doxorubicin. After 48 h of exposure,
doxorubicin elevated the expression of OPN mRNA in both A549
(Figure 3A) and MLE12 (Figure S4), and resulted in increased
accumulation of OPN in A549 cell culture media (Figure 3B).
These data suggest that treatment with doxorubicin also induces
the expression of OPN mRNA as well as the subsequent
production of OPN in AEC II.
Next, we examined whether exposure of AEC II to doxorubicin
can also induce activation of the ERK-dependent signaling
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pathway. ERK1/2 phosphorylation was induced in A549 after
24 h of exposure to 50 nM doxorubicin, without significant
changes to total ERK1/2 protein levels (Figure 3C). To confirm
these results, MLE12 were exposed to 50 nM doxorubicin. In
MLE12, Erk1/2 phosphorylation was induced after 36 h of
exposure, without significant changes to total Erk1/2 protein levels
(Figure S5).
To determine whether the ERK-dependent signaling pathway
was responsible for doxorubicin-mediated expression of OPN, we
exposed both cell lines to 50 nM doxorubicin for 48 h after
Figure 1. Effect of bleomycin on OPN expression in type II alveolar epithelial cell lines. (A) A549 were exposed to 1 mg/mL bleomycin for
0, 6, 12, 24 and 48 h. OPN mRNA was assessed by qRT-PCR. (B) MLE12 were exposed to 1 mg/mL bleomycin for 0, 6, 12, 24 and 48 h. Opn mRNA was
assessed by qRT-PCR. (C) A549 were exposed to 0, 1 and 10 mg/mL bleomycin for 48 h. OPN mRNA was assessed by qRT-PCR. (D) MLE12 were
exposed to 0, 1 and 10 mg/mL bleomycin for 48 h. Opn mRNA was assessed by qRT-PCR. (E, F and G) A549 were exposed to 1 mg/mL bleomycin.
(E) The cells were lysed at 0, 2, 4 and 6 d. OPN concentrations in cell lysates were determined by ELISA. (F) The cell culture supernatants were
collected at 0, 2, 4 and 6 d. OPN concentrations in cell culture media were determined by ELISA. (G) Total OPN concentrations in cell lysates and cell
culture media were determined by ELISA. Data are presented as mean 6 S.E. *, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0100106.g001
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treatment with either PD98059 (50 mM) or U0126 (50 mM), and
found that the ERK1/2 phosphorylation was inhibited without
significant changes to total ERK1/2 protein levels in both A549
(Figures 3D and 3E) and MLE12 (Figures S6A and S6B). A549
and MLE12 were also pretreated with either PD98059 (50 mM) or
U0126 (50 mM) for 1 h, prior to exposure to 50 nM doxorubicin
or PBS for an additional 48 h. The presence of these inhibitors
significantly reduced the expression of OPN mRNA in both A549
(Figures 3F and 3G) and MLE12 (Figures S7A and S7B), as well as
the accumulation of OPN in A549 cell culture media (Figures 3H
and 3I). These data suggest that DNA damage caused not only by
bleomycin, but also by doxorubicin, activates the ERK-dependent
signaling pathway in AEC II and induces OPN expression.
Tunicamycin-induced OPN mRNA expression in AEC II via
activation of the ERK-dependent signaling pathway
ER stress is associated with familial or sporadic IPF [17,18].
Therefore, we examined the relationship between ER stress and
OPN expression. We used tunicamycin as an ER-stress inducer
[19] and determined the expression of BiP protein as a marker of
ER stress [20]. A549 and MLE12 were exposed to 0.5 mg/mL and
0.025 mg/mL tunicamycin, respectively. After 48 h, tunicamycin
upregulated BiP protein levels and induced the expression of OPN
mRNA in both A549 (Figures 4A and 4B) and MLE12 (Figures S8
and S9). These data indicate that treatment with tunicamycin
induces OPN mRNA expression in AEC II. In contrast to
bleomycin and doxorubicin exposure, however, the accumulation
of OPN in A549 cell culture media was not increased after
exposure to tunicamycin (data not shown).
Figure 2. Molecular mechanism of OPN induction after exposure to bleomycin. (A) A549 were exposed to 10 mg/mL bleomycin or PBS for
24 h. Western blotting was used to detect phospho-specific ERK1/2, ERK1/2, phospho-specific SAPK/JNK, SAPK/JNK, phospho-specific p38 MAPK and
p38 MAPK. (B) A549 were pretreated with PD98059 (50 mM) or DMSO for 1 h, and subsequently exposed to 10 mg/mL bleomycin for 48 h. Western
blotting was used to detect phospho-specific ERK1/2 and ERK1/2. (C) A549 were pretreated with U0126 (50 mM) or DMSO for 1 h, and subsequently
exposed to 10 mg/mL bleomycin for 48 h. Western blotting was used to detect phospho-specific ERK1/2 and ERK1/2. (D) A549 were pretreated with
PD98059 (50 mM) or DMSO for 1 h, and subsequently exposed to 10 mg/mL bleomycin or PBS for 48 h. OPNmRNA was assessed by qRT-PCR. (E) A549
were pretreated with U0126 (50 mM) or DMSO for 1 h, and subsequently exposed to 10 mg/mL bleomycin or PBS for 48 h. OPN mRNA was assessed
by qRT-PCR. (F) A549 were pretreated with PD98059 (50 mM) or DMSO for 1 h, and subsequently exposed to 10 mg/mL bleomycin or PBS for 48 h.
OPN concentrations in cell culture media were determined by ELISA. (G) A549 were pretreated with U0126 (50 mM) or DMSO for 1 h, and
subsequently exposed to 10 mg/mL bleomycin or PBS for 48 h. OPN concentrations in cell culture media were determined by ELISA. Data are
presented as mean 6 S.E. *, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0100106.g002
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Figure 3. Effect of doxorubicin on OPN expression and molecular mechanism of OPN induction. (A and B) A549 were exposed to 50 nM
doxorubicin or PBS for 48 h. (A) OPN mRNA was assessed by qRT-PCR. (B) OPN concentrations in cell culture media were determined by ELISA. (C)
A549 were exposed to 50 nM doxorubicin or PBS for 24 h. Western blotting was used to detect phospho-specific ERK1/2 and ERK1/2. (D) A549 were
pretreated with PD98059 (50 mM) or DMSO for 1 h, and subsequently exposed to 50 nM doxorubicin for 48 h. Western blotting was used to detect
phospho-specific ERK1/2 and ERK1/2. (E) A549 were pretreated with U0126 (50 mM) or DMSO for 1 h, and subsequently exposed to 50 nM
doxorubicin for 48 h. Western blotting was used to detect phospho-specific ERK1/2 and ERK1/2. (F) A549 were pretreated with PD98059 (50 mM) or
DMSO for 1 h, and subsequently exposed to 50 nM doxorubicin or PBS for 48 h. OPN mRNA was assessed by qRT-PCR. (G) A549 were pretreated with
U0126 (50 mM) or DMSO for 1 h, and subsequently exposed to 50 nM doxorubicin or PBS for 48 h. OPN mRNA was assessed by qRT-PCR. (H) A549
were pretreated with PD98059 (50 mM) or DMSO for 1 h, and subsequently exposed to 50 nM doxorubicin or PBS for 48 h. OPN concentrations in cell
culture media were determined by ELISA. (I) A549 were pretreated with U0126 (50 mM) or DMSO for 1 h, and subsequently exposed to 50 nM
doxorubicin or PBS for 48 h. OPN concentrations in cell culture media were determined by ELISA. Data are presented as mean 6 S.E. *, P,0.05; **,
P,0.01.
doi:10.1371/journal.pone.0100106.g003
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Subsequently, we examined whether the exposure of AEC II to
tunicamycin induced the activation of the ERK-dependent
signaling pathway. ERK1/2 phosphorylation was induced in
A549 after 24 h of exposure to 0.5 mg/mL tunicamycin, without
significant changes to total ERK1/2 protein levels (Figure 4C). To
confirm these results, MLE12 were exposed to 0.025 mg/mL
tunicamycin. In MLE12, Erk1/2 phosphorylation was induced
after 36 h of exposure, without significant changes to total Erk1/2
protein levels (Figure S10).
Further, we sought to determine whether the ERK-dependent
signaling pathway was responsible for tunicamycin-mediated
expression of OPN mRNA. After 48 h exposure to tunicamycin,
both PD98059 (50 mM) and U0126 (50 mM) were found to inhibit
ERK1/2 phosphorylation without significant changes to total
ERK1/2 protein levels in A549 (Figures 4D and 4E) and MLE12
(Figures S11A and S11B). A549 were pretreated with PD98059
(50 mM) or U0126 (50 mM) for 1 h, prior to exposure to 0.5 mg/
mL tunicamycin or DMSO for an additional 48 h. These
inhibitors significantly reduced the expression of OPN mRNA
(Figures 4F and 4G). Similar results were obtained when MLE12
pretreated with PD98059 (50 mM) or U0126 (50 mM) for 1 h were
subsequently exposed to 0.025 mg/mL tunicamycin (Figures S12A
and S12B). Taken together, these results suggest that tunicamycin-
induced ER stress also activates the ERK-dependent signaling
pathway in AEC II, and induces the expression of OPN mRNA.
Thapsigargin-induced OPN expression in AEC II
Treatment with tunicamycin induces the expression of OPN
mRNA; however, it does not increase the accumulation of OPN in
A549 cell culture media. To confirm the relationship between ER
stress and OPN expression, we investigated the use of another
reagent that induces ER stress, namely thapsigargin. Thapsigargin
induces ER stress by inhibiting Ca2+-ATPase in ER [21]. A549
and MLE12 were exposed to 10 nM and 5 nM thapsigargin,
respectively. After 48 h, thapsigargin upregulated BiP protein
levels and induced the expression of OPN mRNA in both A549
Figure 4. Effect of tunicamycin on OPN expression and molecular mechanism of OPN induction. (A) A549 were exposed to 0.5 mg/mL
tunicamycin or DMSO for 48 h. Western blotting was used to detect BiP and b-actin. (B) A549 were exposed to 0.5 mg/mL tunicamycin or DMSO for
48 h. OPN mRNA was assessed by qRT-PCR. (C) A549 were exposed to 0.5 mg/mL tunicamycin or DMSO for 24 h. Western blotting was used to detect
phospho-specific ERK1/2 and ERK1/2. (D) A549 were pretreated with PD98059 (50 mM) or DMSO for 1 h, and subsequently exposed to 0.5 mg/mL
tunicamycin for 48 h. Western blotting was used to detect phospho-specific ERK1/2 and ERK1/2. (E) A549 were pretreated with U0126 (50 mM) or
DMSO for 1 h, and subsequently exposed to 0.5 mg/mL tunicamycin for 48 h. Western blotting was used to detect phospho-specific ERK1/2 and
ERK1/2. (F) A549 were pretreated with PD98059 (50 mM) or DMSO for 1 h, and subsequently exposed to 0.5 mg/mL tunicamycin or DMSO for 48 h.
OPN mRNA was assessed by qRT-PCR. (G) A549 were pretreated with U0126 (50 mM) or DMSO for 1 h, and subsequently exposed to 0.5 mg/mL
tunicamycin or DMSO for 48 h. OPN mRNA was assessed by qRT-PCR. Data are presented as mean 6 S.E. *, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0100106.g004
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(Figures 5A and 5B) and MLE12 (Figures S13 and S14).
Subsequently, we sought to determine whether thapsigargin would
induce the production of OPN in A549 cell culture media. The
accumulation of OPN in A549 cell culture media was increased
after 48 h exposure to thapsigargin (Figure 5C). These data
indicate that thapsigargin induces the expression of OPN mRNA
and subsequent production of OPN in AEC II.
Knockdown of OPN suppresses the proliferation of AEC II
To assess the function of upregulated OPN in AEC II, human
OPN siRNA was transfected into A549 at 20 nM. The expression
of OPN mRNA (Figure 6A) and accumulation of OPN in cell
culture media (Figure 6B) were significantly suppressed 3 d after
transfection, regardless of the presence or absence of bleomycin
exposure. Twenty-four h after the transfection of human OPN
siRNA or control siRNA, A549 were exposed to 1 mg/mL
bleomycin for 48 h. Thereafter, A549 were incubated with EdU
for an additional 15 h. The nuclei of all cells showed blue
fluorescence after treatment with HCS NuclearMask Blue stain
(Figure 6C i and ii). Proliferating cells incorporate EdU into newly
synthesized DNA as a nucleoside analog of thymidine. Conse-
quently, the nuclei of proliferating cells showed green fluorescence
as EdU-positive nuclei after treatment with Alexa Fluor azide
(Figure 6C iii and iv). Twelve fields per well were recorded with
the Floid Cell Imaging Station and the number of positively-
staining cells was counted. In A549 transfected with human OPN
siRNA, the percentage of proliferating cells was significantly
decreased compared with those transfected with control siRNA
(Figure 6D). This suggests that the expression of OPN by AEC II
promotes self-proliferation in an autocrine manner.
OPN protein in cell culture medium promotes the
migration of lung fibroblasts
The migration of lung fibroblasts into the alveolar space is
important for the evolution of intra-alveolar fibrosis, a step in the
pathogenesis of IPF [22]. We assessed the effect of OPN on the
migration of lung fibroblasts. First, we generated conditioned
medium by exposing A549 to 1 mg/mL bleomycin in serum-free
DMEM for 48 h. The concentration of OPN in the conditioned
medium was approximately 1.05 mg/mL as determined by
ELISA. NHLFs were cultured with DMEM supplemented with
0.1% FBS and antibiotics for 18 h for serum starvation. These
cells were resuspended in serum-free DMEM and seeded into the
upper chamber at 15,000 cells/well. The lower chamber was filled
with either conditioned medium +4 mg/mL control IgG, condi-
tioned medium +4 mg/mL anti-OPN IgG, or serum-free DMEM+
4 mg/mL control IgG. The cell index was monitored automatically
every 15 minutes for at least 24 h with the xCELLigence RTCA
DP instrument. NHLFs migrated toward the conditioned medium
after 24 h (conditioned medium + control IgG vs. serum-free
DMEM + control IgG: 0.6160.03 vs. 0.1360.05, P,0.01).
Moreover, the migration of NHLFs was significantly suppressed by
anti-human OPN neutralizing antibody (conditioned medium +
control IgG vs. conditioned medium + anti-OPN IgG: 0.6160.03
vs. 0.4360.03, P,0.01) (Figure 7A). In some cases, the lower
chamber was filled with either serum-free DMEM+1 mg/mL
recombinant human OPN+4 mg/mL control IgG, serum-free
DMEM+1 mg/mL recombinant human OPN+4 mg/mL anti-
OPN IgG, or serum-free DMEM+4 mg/mL control IgG. The
cell index was monitored similarly. We also found that after 24 h,
NHLFs migrated toward serum-free DMEM to which 1 mg/mL
recombinant human OPN was added (serum-free DMEM +
recombinant human OPN + control IgG vs. serum-free DMEM +
control IgG: 0.2660.03 vs. 0.0660.04, P,0.01). The migration of
NHLFs was significantly suppressed by anti-OPN IgG (serum-free
DMEM + recombinant human OPN + control IgG vs. serum-free
DMEM + recombinant human OPN + anti-OPN IgG: 0.2660.03
vs. 0.1660.02, P,0.05) (Figure 7B). These results suggest that the
OPN produced in cell culture medium by AEC II after bleomycin
treatment promotes the migration of lung fibroblasts.
Bleomycin-, doxorubicin- and tunicamycin-induced OPN
expression in HPAEpiC
To determine whether bleomycin, doxorubicin and tunicamy-
cin can alter OPN mRNA expression in normal human pulmonary
alveolar epithelial cells, HPAEpiC were exposed to either 1 mg/
mL bleomycin, 50 nM doxorubicin, or 0.025 mg/mL tunicamy-
cin. The expression of OPN mRNA was elevated after 48 h
exposure to bleomycin, doxorubicin or tunicamycin (Figures 8A,
8B and 8C). Subsequently, we sought to determine whether
bleomycin or doxorubicin would induce the production of OPN
by HPAEpiC. The accumulation of OPN in HPAEpiC cell culture
media was upregulated after 48 h exposure to bleomycin or
doxorubicin (Figures 8D and 8E). Our results suggest that these 3
reagents induce OPN production in normal human alveolar
Figure 5. Effect of thapsigargin on OPN expression. (A) A549 were exposed to 10 nM thapsigargin or DMSO for 48 h. Western blotting was
used to detect BiP and b-actin. (B and C) A549 were exposed to 10 nM thapsigargin or DMSO for 48 h. (B) OPN mRNA was assessed by qRT-PCR. (C)
OPN concentrations in cell culture media were determined by ELISA. Data are presented as mean 6 S.E. *, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0100106.g005
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epithelial cells as well as in human and murine alveolar epithelial
cell lines.
Discussion
The natural history and pathogenesis of IPF remain poorly
understood. Accumulating evidence suggests that IPF may result
from the aberrant migration, proliferation and activation of
mesenchymal cells provoked when alveolar epithelial cells are
subjected to repetitive stress [22]. On the other hand, OPN is a
fibrogenic cytokine [6,7] and its expression is elevated in
hyperplastic AEC II of human IPF and murine bleomycin-
induced lung fibrosis [7–9]. We hypothesized that OPN might
play a role in fibrogenesis of the lung and, therefore, studied the
mechanism of OPN induction in AEC II and elucidated the
functions of OPN in AEC II and lung fibroblasts.
Bleomycin and doxorubicin both cause cellular injury through
DNA damage [4,16]. The present study clearly demonstrates that
DNA damage in AEC II caused by bleomycin or doxorubicin
induces OPN expression via activation of the ERK-dependent
signaling pathway (Figures 1–3 and S1–S7). However, it seems
that OPN expression was not directly induced by bleomycin or
doxorubicin, because the expression of OPN mRNA gradually
increased and its induction was observed after 48 h exposure to
either bleomycin or doxorubicin. The expression of OPN is
induced by various cytokines, such as tumor necrosis factor-a
(TNF-a), platelet-derived growth factor, angiotensin II and
interleukin-1b [12,23-25]. Thus, it is possible that bleomycin
and doxorubicin may have induced cytokines, such as TNF-a, and
that those cytokines might, in turn, have induced the expression of
OPN.
Patients with familial IPF account for less than 5% of all IPF
cases [26]. However, many investigators have studied familial IPF
to understand the pathogenesis of IPF, and results suggest that
mutations in the SFTPC gene (encoding surfactant protein C) and
the SFTPA2 gene (encoding surfactant protein A2) occur in
familial IPF. These mutations are likely associated with repetitive
injury to alveolar epithelial cells, and cause the unfolding and
misfolding of proteins in the ER [17,18], a potentially major
source of stress that could induce pulmonary fibrosis. Tunicamycin
inhibits glycoprotein synthesis by inhibition of N-linked glycosyl-
Figure 6. Effect of OPN on the proliferation of A549. (A and B) A549 were transfected with 20 nM human OPN siRNA or control siRNA. Twenty-
four h after transfection, A549 were incubated for 48 h in the presence of 1 mg/mL bleomycin or PBS. (A) OPN mRNA was assessed by qRT-PCR.
(B) OPN concentrations in cell culture media were determined by ELISA. (C and D) A549 were transfected with 20 nM human OPN siRNA or control
siRNA. Twenty-four h after transfection, A549 were exposed to 1 mg/mL bleomycin for 48 h and then incubated with EdU for an additional 15 h. A549
were stained with Alexa Fluor 488 azide and HCS NuclearMask Blue stain. The cells were visualized by pseudocoloring with the Floid Cell Imaging
Station. (C) Nuclei (i, ii) show representative photomicrographs of all cells. EdU (iii, iv) show representative photomicrographs of proliferating cells.
Merge (v, vi) show representative photomicrographs of merged images. Bar: 100 mm. (D) Twelve fields per well were recorded and the number of
positively-staining cells was counted. The percentages of proliferating A549 that were transfected with either human OPN siRNA or control siRNA are
shown. Data are presented as mean 6 S.E. *, P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0100106.g006
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ation in the ER and thereby induces ER-stress [19,27]. Therefore,
we evaluated tunicamycin, an ER-stress inducer, could induce the
expression of OPN in AEC II. The exposure of AEC II to
tunicamycin was found to induce the expression of OPN mRNA
via activation of the ERK-dependent signaling pathway (Figures 4
and S8 - S12). However, the accumulation of OPN in A549 cell
culture media was not increased (data not shown). Tunicamycin
induces ER stress by inhibiting the first step in the N-linked
glycosylation of glycoproteins [27]. Moreover, the fact that OPN is
an N-linked glycoprotein, and that glycosylation is necessary for
the secretion of glycoproteins [27], suggests a reason for why the
accumulation of OPN in cell culture media was not increased
during tunicamycin treatment. To confirm the relationship
between ER stress and OPN expression, we investigated the use
of another reagent that induces ER stress, namely thapsigargin.
Thapsigargin inhibits the Ca2+-ATPase in ER and thereby induces
ER stress [21]. Thapsigargin induced the expression of OPN
mRNA in A549 and the accumulation of OPN in A549 cell
Figure 7. Effect of OPN on the migration of lung fibroblasts. (A and B) The migration of NHLFs was assessed with a xCELLigence RTCA DP
instrument. Serum-starved NHLFs were resuspended in serum-free DMEM and seeded into the upper chamber at 15,000 cells/well. (A) Conditioned
medium was made by exposing A549 to 1 mg/mL bleomycin in serum-free DMEM for 48 h. The lower chamber was filled with either conditioned
medium +4 mg/mL control IgG, conditioned medium +4 mg/mL anti-OPN IgG, or serum-free DMEM+4 mg/mL control IgG. The cell index was
monitored automatically every 15 minutes for at least 24 h. The vertical axis shows the change of cell index from the time when the CIM-plate 16
containing NHLFs was set into the xCELLigence RTCA DP instrument. (B) The lower chamber was filled with either serum-free DMEM+1 mg/mL
recombinant human OPN+4 mg/mL control IgG, serum-free DMEM+1 mg/mL recombinant human OPN+4 mg/mL anti-OPN IgG, or serum-free DMEM+
4 mg/mL control IgG. The cell index was monitored automatically every 15 minutes for at least 24 h. The vertical axis shows the change of cell index
from the time when the CIM-plate 16 containing NHLFs was set into the xCELLigence RTCA DP instrument. Data are presented as mean 6 S.E. *,
P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0100106.g007
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culture media (Figures 5, S13 and S14). ERK1/2 is strongly
activated in the lung tissue of patients during the early stages of
IPF [28]. This activation protects AEC II against oxygen-induced
DNA damage and apoptosis [29]. According to the results of this
study, as well as previous reports, OPN might be expressed as a
survival factor for AEC II. We also examined the effect of OPN on
AEC II, and have demonstrated here, as well as in a previous
study [7], that OPN promotes the proliferation of AEC II
(Figure 6). Apoptosis of AEC II is associated with the destruction
of alveolar epithelium in IPF [30,31]. Considering these results,
bleomycin-induced OPN may protect AEC II against DNA
damage.
Both the migration and accumulation of lung fibroblasts into the
alveolar spaces are essential for the development of intra-alveolar
fibrosis, a pathologic step in the development of IPF. Therefore,
we examined the effect of OPN on lung fibroblasts. The results of
this study suggest that OPN promotes the migration of lung
fibroblasts (Figure 7), confirming the results of a previous study [6].
Taken together, these results suggest that OPN is a chemoat-
tractant for fibrogenesis of the lung.
In conclusion, we have demonstrated that DNA damage caused
by both bleomycin and doxorubicin [4,16], as well as ER stress
caused by tunicamycin [5], induces the expression of OPN in AEC
II via activation of the ERK-dependent signaling pathway. The
induced OPN promotes the proliferation of AEC II and migration
of lung fibroblasts. Moreover, proliferation of AEC II by OPN
induces further OPN production. Based on these results, OPN
might function as a survival factor for AEC II. However, excessive
OPN might be associated with the abnormal repair that causes
fibrogenesis. To better understand the relationship between OPN
and fibrogenesis of the lung, further studies using in vivo murine
models of lung fibrosis are needed.
Supporting Information
Figure S1 Bleomycin induced Erk1/2 phospholylation in
MLE12. MLE12 were exposed to 10 mg/mL bleomycin or PBS
for 36 h. Western blotting was used to detect phospho-specific
Erk1/2 and Erk1/2.
(TIF)
Figure S2 ERK1/2 inhibitors inhibited Erk1/2 phospholylation
after beomycin exposure in MLE12. (A) MLE12 were pretreated
with PD98059 (50 mM) or DMSO for 1 h, and subsequently
exposed to 10 mg/mL bleomycin for 48 h. Western blotting was
used to detect phospho-specific Erk1/2 and Erk1/2. (B) MLE12
were pretreated with U0126 (50 mM) or DMSO for 1 h, and
subsequently exposed to 10 mg/mL bleomycin for 48 h. Western
blotting was used to detect phospho-specific Erk1/2 and Erk1/2.
(TIF)
Figure 8. Effect of bleomycin, doxorubicin or tunicamycin on OPN expression in human pulmonary alveolar epithelial cells. (A)
HPAEpiC were exposed to 1 mg/mL bleomycin for 48 h. OPN mRNA was assessed by qRT-PCR. (B) HPAEpiC were exposed to 50 nM doxorubicin for
48 h. OPN mRNA was assessed by qRT-PCR. (C) HPAEpiC were exposed to 0.025 mg/mL tunicamycin for 48 h. OPN mRNA was assessed by qRT-PCR.
(D) HPAEpiC were exposed to 1 mg/mL bleomycin for 48 h. OPN concentrations in cell culture media were determined by ELISA. (E) HPAEpiC were
exposed to 50 nM doxorubicin for 48 h. OPN concentrations in cell culture media were determined by ELISA. Data are presented as mean 6 S.E. *,
P,0.05; **, P,0.01.
doi:10.1371/journal.pone.0100106.g008
Cell Stress Induces OPN via the ERK Pathway
PLOS ONE | www.plosone.org 11 June 2014 | Volume 9 | Issue 6 | e100106
Figure S3 ERK1/2 inhibitors reduced the expression of Opn
mRNA after bleomycin exposure in MLE12. (A) MLE12 were
pretreated with PD98059 (50 mM) or DMSO for 1 h, and
subsequently exposed to 10 mg/mL bleomycin or PBS for 48 h.
Opn mRNA was assessed by qRT-PCR. (B) MLE12 were
pretreated with U0126 (50 mM) or DMSO for 1 h, and
subsequently exposed to 10 mg/mL bleomycin or PBS for 48 h.
Opn mRNA was assessed by qRT-PCR. Data are presented as
mean 6 S.E. *, P,0.05; **, P,0.01.
(TIF)
Figure S4 Doxorubicin induced the expression of Opn mRNA in
MLE12. MLE12 were exposed to 50 nM doxorubicin or PBS for
48 h. Opn mRNA was assessed by qRT-PCR. Data are presented
as mean 6 S.E. *, P,0.05; **, P,0.01.
(TIF)
Figure S5 Doxorubicin induced Erk1/2 phospholylation in
MLE12. MLE12 were exposed to 50 nM doxorubicin or PBS for
36 h. Western blotting was used to detect phospho-specific Erk1/2
and Erk1/2.
(TIF)
Figure S6 ERK1/2 inhibitors inhibited Erk1/2 phospholylation
after doxorubicin exposure in MLE12. (A) MLE12 were
pretreated with PD98059 (50 mM) or DMSO for 1 h, and
subsequently exposed to 50 nM doxorubicin for 48 h. Western
blotting was used to detect phospho-specific Erk1/2 and Erk1/2.
(B) MLE12 were pretreated with U0126 (50 mM) or DMSO for
1 h, and subsequently exposed to 50 nM doxorubicin for 48 h.
Western blotting was used to detect phospho-specific Erk1/2 and
Erk1/2.
(TIF)
Figure S7 ERK1/2 inhibitors reduced the expression of Opn
mRNA after doxorubicin exposure in MLE12. (A) MLE12 were
pretreated with PD98059 (50 mM) or DMSO for 1 h, and
subsequently exposed to 50 nM doxorubicin or PBS for 48 h.
Opn mRNA was assessed by qRT-PCR. (B) MLE12 were
pretreated with U0126 (50 mM) or DMSO for 1 h, and
subsequently exposed to 50 nM doxorubicin or PBS for 48 h.
Opn mRNA was assessed by qRT-PCR. Data are presented as
mean 6 S.E. *, P,0.05; **, P,0.01.
(TIF)
Figure S8 Tunicamycin induced the expression of BiP protein in
MLE12. MLE12 were exposed to 0.025 mg/mL tunicamycin or
DMSO for 48 h. Western blotting was used to detect BiP and b-
actin.
(TIF)
Figure S9 Tunicamycin induced the expression of Opn mRNA
in MLE12. MLE12 were exposed to 0.025 mg/mL tunicamycin or
DMSO for 48 h. Opn mRNA was assessed by qRT-PCR. Data are
presented as mean 6 S.E. *, P,0.05; **, P,0.01.
(TIF)
Figure S10 Tunicamycin induced Erk1/2 phospholylation in
MLE12. MLE12 were exposed to 0.025 mg/mL tunicamycin or
DMSO for 36 h. Western blotting was used to detect phospho-
specific Erk1/2 and Erk1/2.
(TIF)
Figure S11 ERK1/2 inhibitors inhibited Erk1/2 phospholyla-
tion after tunicamycin exposure in MLE12. (A) MLE12 were
pretreated with PD98059 (50 mM) or DMSO for 1 h, and
subsequently exposed to 0.025 mg/mL tunicamycin for 48 h.
Western blotting was used to detect phospho-specific Erk1/2 and
Erk1/2. (B) MLE12 were pretreated with U0126 (50 mM) or
DMSO for 1 h, and subsequently exposed to 0.025 mg/mL
tunicamycin for 48 h. Western blotting was used to detect
phospho-specific Erk1/2 and Erk1/2.
(TIF)
Figure S12 ERK1/2 inhibitors reduced the expression of Opn
mRNA after tunicamycin exposure in MLE12. (A) MLE12 were
pretreated with PD98059 (50 mM) or DMSO for 1 h, and
subsequently exposed to 0.025 mg/mL tunicamycin or DMSO
for 48 h. Opn mRNA was assessed by qRT-PCR. (B) MLE12 were
pretreated with U0126 (50 mM) or DMSO for 1 h, and
subsequently exposed to 0.025 mg/mL tunicamycin or DMSO
for 48 h. Opn mRNA was assessed by qRT-PCR. Data are
presented as mean 6 S.E. *, P,0.05; **, P,0.01.
(TIF)
Figure S13 Thapsigargin induced the expression of BiP protein
in MLE12. MLE12 were exposed to 5 nM thapsigargin or DMSO
for 48 h. Western blotting was used to detect BiP and b-actin.
(TIF)
Figure S14 Thapsigargin induced the expression of Opn mRNA
in MLE12. MLE12 were exposed to 5 nM thapsigargin or DMSO
for 48 h. Opn mRNA was assessed by qRT-PCR. Data are
presented as mean 6 S.E. *, P,0.05; **, P,0.01.
(TIF)
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